ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESR01

A novel Lyme disease vaccine

Active
Institution
Yale University, CT
Principal investigator
Erol Fikrig
Funding
$1.3M
Duration
2022–2027
Open portfolio

Moonbase score

Still being scored

Abstract

PROJECT SUMMARY A novel vaccine for Lyme disease Acquired resistance to Ixodes scapularis, commonly known as “tick resistance”, can prevent transmission of Borrelia burgdorferi, the Lyme disease agent. We have shown that tick resistance can be generated in guinea pigs (1) repeatedly exposed to I. scapularis, (2) immunized with I. scapularis saliva, or (3) immunized with a lipid nanoparticle containing mRNAs encoding 19 saliva proteins (19ISP). In addition, salivary protein 14 (Salp14), a component of 19ISP, elicits partial tick resistance. The goal of this proposal is to identify the specific proteins in I. scapularis saliva that elicit tick resistance and demonstrate that vaccination with these proteins can prevent B. burgdorferi infection. We will delineate the importance of Salp14 and additional saliva proteins in tick resistance, determine the host responses that are associated with tick resistance, and examine whether vaccination with saliva proteins or mRNAs encoding each saliva protein can prevent B. burgdorferi infection. These studies will lead to new knowledge to aid in the development of a novel vaccine which may prevent Lyme disease and, possibly, other tick-borne infections.

Research team

  • Joseph Edgar CraftPI
  • Erol FikrigPI

LOADING MOONBASE SCORE

R01NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESVaccines Against Microbial Diseases Study Section[VMD]immunizedmrnasresistancesalivalymeburgdorferilyme diseasetick

Questions for Yale University

Answered by the team behind this research.

No questions yet. Sign in to ask the first one

Related grants

Same researchers, same institution, same topic, scored first.